Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
Subclinical myocardial dysfunction in multiple sclerosis patients remotely treated with mitoxantrone: evidence of persistent diastolic dysfunction.
Comparative miRNA-Based Fingerprinting Reveals Biological Differences in Human Olfactory Mucosa- and Bone-Marrow-Derived Mesenchymal Stromal Cells.
Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.
Getting a Handle on Lymphopenia With Tecfidera
Glatiramer Acetate Guards Against Rapid Memory Decline During Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
Product Portfolio, Meda
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging.
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Drugs@FDA (Enter "glatiramer acetate" in search box.)
Radiologically isolated syndrome: 5-year risk for an initial clinical event.
Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis.
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Beginning of the end of two-stage theory purporting that inflammation then degeneration explains pathogenesis of progressive multiple sclerosis.
Effect of disease duration on personality type in multiple sclerosis patients and healthy individual.
Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research.
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.

Pages